We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Hikma Pharmaceuticals Plc | LSE:HIK | London | Ordinary Share | GB00B0LCW083 | ORD SHS 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
41.00 | 2.26% | 1,854.00 | 1,839.00 | 1,841.00 | 1,882.00 | 1,750.00 | 1,750.00 | 760,985 | 16:35:14 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 2.88B | 192M | 0.8685 | 21.19 | 4.07B |
Date | Subject | Author | Discuss |
---|---|---|---|
01/10/2014 07:33 | Yep, just seen it. Hikma Pharmaceuticals has received approval of its new drug application for colchicine 0.6mg capsules by the US Food and Drug Administration. Hikma will market its colchicine under the brand name MITIGARE. MITIGARE is indicated for prophylaxis of gout flares in adults. This NDA has been approved under section 505(b)(2) of the US Federal Food Drug and Cosmetic Act. Hikma chairman and chief executive Said Darwazah said: "This approval demonstrates our strong regulatory capabilities and the successful execution of our strategy to develop a more differentiated product portfolio for the US market | broadwood | |
30/9/2014 18:16 | FDA APPROVAL FOR COLCHICINE | mirabeau | |
30/9/2014 17:02 | No new broker recs so its a mystery. Not complaining. | broadwood | |
30/9/2014 16:00 | Someone knows something, nice rise today | coppertrader | |
30/9/2014 12:21 | not any I am aware of. | r ball | |
30/9/2014 11:37 | Going nicely today. Special factors? | broadwood | |
29/9/2014 09:15 | HIKMA Pharmaceuticals, which manufactures generic pharmaceutical products, is reportedly looking at buying US-based rival CorePharma for up to $1bn (£615m). | broadwood | |
19/9/2014 04:46 | Turbulence. Ignore | r ball | |
18/9/2014 00:20 | Does anyone know why this is sinking after it has just released an update with a 45% rise in profits? Is it this scottish debarcle or more to do with the reduction in their labeled drugs? | coppertrader | |
04/9/2014 17:45 | Good article, thanks cla | coppertrader | |
21/8/2014 16:46 | Normal service resumed. | broadwood | |
20/8/2014 23:20 | Looking like it's an over-reaction to pressure on branded sales due to middle-east turmoil. The overall results remain fantastic and regardless of ME, this is still a massively profitable business with great growth prospects. I imagine the drop will be be seen as a buying opportunity tomorrow. | stdyeddy | |
20/8/2014 13:46 | What happened at 11am? Results call? Price was down 20p til then and suddenly it nose-dived.... | adamb1978 | |
20/8/2014 13:41 | Did I miss something? Was this really a profit warning? Branded is forecast down but overall the business is massively up. | stdyeddy | |
20/8/2014 13:36 | Well there you have it; the market has spoken. Evidently +44% is rubbish. What a terrible set of numbers! Why can't Hikma make 10% like everyone else and whine about currency headwinds? Am really not surprised that the stock is down 8%. I certainly hope they don't manage a 100% profit increase next time because I'll probably be wiped out! | stdyeddy | |
20/8/2014 10:21 | Even annualising the interm EPS with no growth, gets you to EPS of about 106p based on FX rate of 1.65, so a PE of just under 16x. For a fast growing mid cap with an unlevered balance sheet and operating in a sector which is rife with M&A activity at the moment, that strikes me as very cheap. Am sturggling to understand why Mr Market doesnt like the results today | adamb1978 | |
20/8/2014 10:21 | Even annualising the interm EPS with no growth, gets you to EPS of about 106p based on FX rate of 1.65, so a PE of just under 16x. For a fast growing mid cap with an unlevered balance sheet and operating in a sector which is rife with M&A activity at the moment, that strikes me as very cheap. Am sturggling to understand why Mr Market doesnt like the results today | adamb1978 | |
20/8/2014 10:16 | COnsensus forecasts of 73p EPS for this year need a massive upgrade surely?!? Am I missing something? | adamb1978 | |
20/8/2014 08:23 | results already in the price. might take a while to digest. | r ball | |
20/8/2014 08:19 | Plus a special dividend! Not good? What was everyone hoping for? | stdyeddy | |
20/8/2014 08:08 | These are great figures: profits up 44%. How come the market isn't reacting positively? | stdyeddy | |
20/8/2014 07:36 | Todays results may get us in. I think an share price of 2000p should do it (around 14% increase from here). | painter | |
15/8/2014 12:27 | The timing is perfect for great results to come out when we are already at an all time high. The way this is going, we will be on the ftse 100 by christmas. | coppertrader | |
25/7/2014 19:41 | Hikma reaching all time highs | mrblonde77 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions